All Publications

  1. Conte MS, Desai TA, Wu B, Schaller M, Werlin E. Pro-resolving lipid mediators in vascular disease. J Clin Invest. 2018 08 31; 128(9):3727-3735. View in PubMed
  2. Wu B, Werlin EC, Chen M, Mottola G, Chatterjee A, Lance KD, Bernards DA, Sansbury BE, Spite M, Desai TA, Conte MS. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model. J Vasc Surg. 2018 Jul 28. View in PubMed
  3. Hiramoto JS, Teraa M, de Borst GJ, Conte MS. Interventions for lower extremity peripheral artery disease. Nat Rev Cardiol. 2018 Jun; 15(6):332-350. View in PubMed
  4. Almasri J, Adusumalli J, Asi N, Lakis S, Alsawas M, Prokop LJ, Bradbury A, Kolh P, Conte MS, Murad MH. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg. 2018 May 24. View in PubMed
  5. van Haelst STW, Teraa M, Moll FL, de Borst GJ, Verhaar MC, Conte MS. Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia. J Vasc Surg. 2018 May 22. View in PubMed
  6. McDermott MM, Spring B, Berger JS, Treat-Jacobson D, Conte MS, Creager MA, Criqui MH, Ferrucci L, Gornik HL, Guralnik JM, Hahn EA, Henke P, Kibbe MR, Kohlman-Trighoff D, Li L, Lloyd-Jones D, McCarthy W, Polonsky TS, Skelly C, Tian L, Zhao L, Zhang D, Rejeski WJ. Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial. JAMA. 2018 04 24; 319(16):1665-1676. View in PubMed
  7. Conte MS. Data, guidelines, and practice of revascularization for claudication. J Vasc Surg. 2017 Sep; 66(3):911-915. View in PubMed
  8. Ramanan B, Ahmed A, Wu B, Causey MW, Gasper WJ, Vartanian SM, Reyzelman AM, Hiramoto JS, Conte MS. Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program. J Vasc Surg. 2017 Dec; 66(6):1765-1774. View in PubMed
  9. Wu B, Mottola G, Schaller M, Upchurch GR, Conte MS. Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications. Mol Aspects Med. 2017 Dec; 58:72-82. View in PubMed
  10. Conte MS. Invited commentary. J Vasc Surg. 2017 Aug; 66(2):505-506. View in PubMed
  11. Schaller MS, Zahner GJ, Gasper WJ, Harris WS, Conte MS, Hills NK, Grenon SM. Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements. J Clin Lipidol. 2017 Sep - Oct; 11(5):1289-1295. View in PubMed
  12. Larsen JT, Shanafelt TD, Leis JF, LaPlant B, Call T, Pettinger A, Hanson C, Erlichman C, Habermann TM, Reeder C, Nikcevich D, Bowen D, Conte M, Boysen J, Secreto C, Lesnick C, Tschumper R, Jelinek D, Kay NE, Ding W. Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study. Am J Hematol. 2017 Aug; 92(8):759-763. View in PubMed
  13. O'Banion LA, Wu B, Eichler CM, Reilly LM, Conte MS, Hiramoto JS. Cryopreserved saphenous vein as a last-ditch conduit for limb salvage. J Vasc Surg. 2017 Sep; 66(3):844-849. View in PubMed
  14. Chatterjee A, Komshian S, Sansbury BE, Wu B, Mottola G, Chen M, Spite M, Conte MS. Biosynthesis of proresolving lipid mediators by vascular cells and tissues. FASEB J. 2017 08; 31(8):3393-3402. View in PubMed
  15. Mottola G, Chatterjee A, Wu B, Chen M, Conte MS. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. PLoS One. 2017; 12(3):e0174936. View in PubMed
  16. Jones WS, Baumgartner I, Hiatt WR, Heizer G, Conte MS, White CJ, Berger JS, Held P, Katona BG, Mahaffey KW, Norgren L, Blomster J, MillegÄrd M, Reist C, Patel MR, Fowkes FG. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease. Circulation. 2017 Jan 17; 135(3):241-250. View in PubMed
  17. Finnes HD, Chaffee KG, Call TG, Ding W, Kenderian SS, Bowen DA, Conte M, McCullough KB, Merten JA, Bartoo GT, Smith MD, Leis J, Chanan-Khan A, Schwager SM, Slager SL, Kay NE, Shanafelt TD, Parikh SA. Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice. Leuk Lymphoma. 2017 06; 58(6):1376-1383. View in PubMed
  18. Baldwin MJ, Policha A, Maldonado T, Hiramoto JS, Honig S, Conte MS, Berger J, Rockman CB. Novel association between bone mineral density scores and the prevalence of peripheral artery disease in both sexes. Vasc Med. 2017 02; 22(1):13-20. View in PubMed
  19. Pope NH, Salmon M, Davis JP, Chatterjee A, Su G, Conte MS, Ailawadi G, Upchurch GR. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization. FASEB J. 2016 12; 30(12):4192-4201. View in PubMed
  20. Lance KD, Chatterjee A, Wu B, Mottola G, Nuhn H, Lee PP, Sansbury BE, Spite M, Desai TA, Conte MS. Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device. J Biomed Mater Res A. 2017 01; 105(1):31-41. View in PubMed
  21. Strati P, Lanasa M, Call TG, Leis JF, Brander DM, LaPlant BR, Pettinger AM, Ding W, Parikh SA, Hanson CA, Chanan-Khan AA, Bowen DA, Conte M, Kay NE, Shanafelt TD. Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial. Lancet Haematol. 2016 Sep; 3(9):e407-14. View in PubMed
  22. Menard MT, Farber A, Assmann SF, Choudhry NK, Conte MS, Creager MA, Dake MD, Jaff MR, Kaufman JA, Powell RJ, Reid DM, Siami FS, Sopko G, White CJ, Rosenfield K. Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial. J Am Heart Assoc. 2016 Jul 08; 5(7). View in PubMed
  23. Wu B, Mottola G, Chatterjee A, Lance KD, Chen M, Siguenza IO, Desai TA, Conte MS. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury. J Vasc Surg. 2017 Jan; 65(1):207-217.e3. View in PubMed
  24. Causey MW, Ahmed A, Wu B, Gasper WJ, Reyzelman A, Vartanian SM, Hiramoto JS, Conte MS. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg. 2016 06; 63(6):1563-1573.e2. View in PubMed
  25. Causey MW, Amans MR, Han S, Higashida RT, Conte M. Reversible cerebral vasoconstriction syndrome is a rare cause of stroke after carotid endarterectomy. J Vasc Surg. 2016 Dec; 64(6):1847-1850. View in PubMed
  26. Teraa M, Conte MS, Moll FL, Verhaar MC. Critical Limb Ischemia: Current Trends and Future Directions. J Am Heart Assoc. 2016 Feb 23; 5(2). View in PubMed
  27. Smith AD, Hawkins AT, Schaumeier MJ, de Vos MS, Conte MS, Nguyen LL. Predictors of major amputation despite patent bypass grafts. J Vasc Surg. 2016 May; 63(5):1279-88. View in PubMed
  28. Abu Dabrh AM, Steffen MW, Asi N, Undavalli C, Wang Z, Elamin MB, Conte MS, Murad MH. Nonrevascularization-based treatments in patients with severe or critical limb ischemia. J Vasc Surg. 2015 Nov; 62(5):1330-9.e13. View in PubMed
  29. Abu Dabrh AM, Steffen MW, Undavalli C, Asi N, Wang Z, Elamin MB, Conte MS, Murad MH. The natural history of untreated severe or critical limb ischemia. J Vasc Surg. 2015 Dec; 62(6):1642-51.e3. View in PubMed
  30. Abu Dabrh AM, Steffen MW, Asi N, Undavalli C, Wang Z, Elamin MB, Conte MS, Murad MH. Bypass surgery versus endovascular interventions in severe or critical limb ischemia. J Vasc Surg. 2016 Jan; 63(1):244-53.e11. View in PubMed
  31. Grenon SM, Owens CD, Nosova EV, Hughes-Fulford M, Alley HF, Chong K, Perez S, Yen PK, Boscardin J, Hellmann J, Spite M, Conte MS. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial). J Am Heart Assoc. 2015 Aug 21; 4(8):e002034. View in PubMed
  32. Han SM, Wu B, Eichler CM, Reilly LM, Vartanian SM, Conte MS, Hiramoto J. Risk Factors for 30-Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease. Vasc Endovascular Surg. 2015 Apr-May; 49(3-4):69-74. View in PubMed
  33. Nosova EV, Bartel K, Chong KC, Alley HF, Conte MS, Owens CD, Grenon SM. Analysis of nutritional habits and intake of polyunsaturated fatty acids in veterans with peripheral arterial disease. Vasc Med. 2015 Oct; 20(5):432-8. View in PubMed
  34. Conte MS, Farber A. Revascularization for chronic limb-threatening ischaemia. Br J Surg. 2015 Aug; 102(9):1007-9. View in PubMed
  35. Oresanya L, Zhao S, Gan S, Fries BE, Goodney PP, Covinsky KE, Conte MS, Finlayson E. Functional outcomes after lower extremity revascularization in nursing home residents: a national cohort study. JAMA Intern Med. 2015 Jun; 175(6):951-7. View in PubMed
  36. Parikh SA, Leis JF, Chaffee KG, Call TG, Hanson CA, Ding W, Chanan-Khan AA, Bowen D, Conte M, Schwager S, Slager SL, Van Dyke DL, Jelinek DF, Kay NE, Shanafelt TD. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes. Cancer. 2015 Sep 01; 121(17):2883-91. View in PubMed
  37. Vartanian SM, Conte MS. Surgical intervention for peripheral arterial disease. Circ Res. 2015 Apr 24; 116(9):1614-28. View in PubMed
  38. Kibbe MR, Dardik A, Velazquez OC, Conte MS. The vascular surgeon-scientist: a 15-year report of the Society for Vascular Surgery Foundation/National Heart, Lung, and Blood Institute-mentored Career Development Award Program. J Vasc Surg. 2015 Apr; 61(4):1050-7. View in PubMed
  39. Akagi D, Chen M, Toy R, Chatterjee A, Conte MS. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice. FASEB J. 2015 Jun; 29(6):2504-13. View in PubMed
  40. Yiu WK, Conte MS. Primary stenting in femoropopliteal occlusive disease - what is the appropriate role? Circ J. 2015; 79(4):704-11. View in PubMed
  41. Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR, Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenfield K, Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H, Krucoff MW. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015 Mar 10; 65(9):931-41. View in PubMed
  42. Tsang M, Shanafelt TD, Call TG, Ding W, Chanan-Khan A, Leis JF, Nowakowski GS, Bowen D, Conte M, Schwager SM, Slager SL, Kay NE, Hanson CA, Parikh SA. The efficacy of ibrutinib in the treatment of Richter syndrome. Blood. 2015 Mar 05; 125(10):1676-8. View in PubMed
  43. Alahdab F, Wang AT, Elraiyah TA, Malgor RD, Rizvi AZ, Lane MA, Prokop LJ, Montori VM, Conte MS, Murad MH. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 2015 Mar; 61(3 Suppl):42S-53S. View in PubMed
  44. Malgor RD, Alahdab F, Alalahdab F, Elraiyah TA, Rizvi AZ, Lane MA, Prokop LJ, Phung OJ, Farah W, Montori VM, Conte MS, Murad MH. A systematic review of treatment of intermittent claudication in the lower extremities. J Vasc Surg. 2015 Mar; 61(3 Suppl):54S-73S. View in PubMed
  45. Conte MS, Pomposelli FB. Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction. J Vasc Surg. 2015 Mar; 61(3 Suppl):1S. View in PubMed
  46. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015 Mar; 61(3 Suppl):2S-41S. View in PubMed
  47. Vartanian SM, Robinson KD, Ofili K, Eichler CM, Hiramoto JS, Reyzelman AM, Conte MS. Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service. Ann Vasc Surg. 2015 Apr; 29(3):534-42. View in PubMed
  48. Nosova EV, Conte MS, Grenon SM. Advancing beyond the "heart-healthy diet" for peripheral arterial disease. J Vasc Surg. 2015 Jan; 61(1):265-74. View in PubMed
  49. Chatterjee A, Sharma A, Chen M, Toy R, Mottola G, Conte MS. The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells. PLoS One. 2014; 9(11):e113480. View in PubMed
  50. Chong KC, Owens CD, Park M, Alley HF, Boscardin WJ, Conte MS, Gasper WJ, Grenon SM. Relationship between kidney disease and endothelial function in peripheral artery disease. J Vasc Surg. 2014 Dec; 60(6):1605-11. View in PubMed
  51. Subherwal S, Patel MR, Chiswell K, Tidemann-Miller BA, Jones WS, Conte MS, White CJ, Bhatt DL, Laird JR, Hiatt WR, Tasneem A, Califf RM. Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the database. Circulation. 2014 Nov 11; 130(20):1812-9. View in PubMed
  52. Conte MS, Goodney PP. Regarding "Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease". J Vasc Surg. 2014 Jul; 60(1):271-2. View in PubMed
  53. Nosova EV, Chong KC, Alley HF, Harris WS, Boscardin WJ, Conte MS, Owens CD, Grenon SM. Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease. J Vasc Surg. 2014 Nov; 60(5):1325-31. View in PubMed
  54. Hiramoto JS, Katz R, Weisman S, Conte M. Gender-specific risk factors for peripheral artery disease in a voluntary screening population. J Am Heart Assoc. 2014 Mar 13; 3(2):e000651. View in PubMed
  55. Walker JP, Hiramoto JS, Gasper WJ, Auyang P, Conte MS, Rapp JH, Lovett DH, Owens CD. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease. J Vasc Surg. 2014 Jul; 60(1):176-83. View in PubMed
  56. Nosova EV, Yen P, Chong KC, Alley HF, Stock EO, Quinn A, Hellmann J, Conte MS, Owens CD, Spite M, Grenon SM. Short-term physical inactivity impairs vascular function. J Surg Res. 2014 Aug; 190(2):672-82. View in PubMed
  57. Owens CD, Gasper WJ, Walker JP, Alley HF, Conte MS, Grenon SM. Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization. J Vasc Surg. 2014 Apr; 59(4):1016-24. View in PubMed
  58. Oresanya L, Makam AN, Belkin M, Moneta GL, Conte MS. Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance. J Vasc Surg. 2014 Apr; 59(4):996-1002. View in PubMed
  59. Jones DW, Schanzer A, Zhao Y, MacKenzie TA, Nolan BW, Conte MS, Goodney PP. Growing impact of restenosis on the surgical treatment of peripheral arterial disease. J Am Heart Assoc. 2013 Nov 25; 2(6):e000345. View in PubMed
  60. Gasper WJ, Jimenez CA, Walker J, Conte MS, Seward K, Owens CD. Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation. Circ Cardiovasc Interv. 2013 Dec; 6(6):701-9. View in PubMed
  61. Mills JL, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014 Jan; 59(1):220-34.e1-2. View in PubMed
  62. Owens CD, Gasper WJ, Rahman AS, Conte MS. Vein graft failure. J Vasc Surg. 2015 Jan; 61(1):203-16. View in PubMed
  63. Ding W, Shanafelt TD, Lesnick CE, Erlichman C, Leis JF, Secreto C, Sassoon TR, Call TG, Bowen DA, Conte M, Kumar S, Kay NE. Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis. Br J Haematol. 2014 Jan; 164(1):146-50. View in PubMed
  64. Grenon SM, Owens CD, Alley H, Chong K, Yen PK, Harris W, Hughes-Fulford M, Conte MS. n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial. Vasc Med. 2013 Oct; 18(5):263-74. View in PubMed
  65. Shanafelt T, Lanasa MC, Call TG, Beaven AW, Leis JF, LaPlant B, Bowen D, Conte M, Jelinek DF, Hanson CA, Kay NE, Zent CS. Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL). Cancer. 2013 Nov 01; 119(21):3788-96. View in PubMed
  66. Parikh SA, Rabe KG, Kay NE, Call TG, Ding W, Schwager SM, Bowen DA, Conte M, Jelinek DF, Slager SL, Shanafelt TD. Chronic lymphocytic leukemia in young (= 55 years) patients: a comprehensive analysis of prognostic factors and outcomes. Haematologica. 2014 Jan; 99(1):140-7. View in PubMed
  67. Vartanian SM, Johnston PC, Walker JP, Runge SJ, Eichler CM, Reilly LM, Hiramoto JS, Conte MS. Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease. J Vasc Surg. 2013 Dec; 58(6):1525-31. View in PubMed
  68. Grenon SM, Vittinghoff E, Owens CD, Conte MS, Whooley M, Cohen BE. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study. Vasc Med. 2013 Aug; 18(4):176-84. View in PubMed
  69. Grenon SM, Conte MS, Nosova E, Alley H, Chong K, Harris WS, Vittinghoff E, Owens CD. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease. J Vasc Surg. 2013 Nov; 58(5):1283-90. View in PubMed
  70. Misra S, Lookstein R, Rundback J, Hirsch AT, Hiatt WR, Jaff MR, White CR, Conte M, Geraghty P, Patel M, Rosenfield K. Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia. J Vasc Interv Radiol. 2013 Apr; 24(4):451-8. View in PubMed
  71. Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, Fitzgerald JM, Serhan CN, Conte MS. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J. 2013 Jun; 27(6):2220-32. View in PubMed
  72. McPhee JT, Nguyen LL, Ho KJ, Ozaki CK, Conte MS, Belkin M. Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia. J Vasc Surg. 2013 Jun; 57(6):1481-8. View in PubMed
  73. Conte MS. Critical appraisal of surgical revascularization for critical limb ischemia. J Vasc Surg. 2013 Feb; 57(2 Suppl):8S-13S. View in PubMed
  74. Kraiss LW, Conte MS, Geary RL, Kibbe M, Ozaki CK. Setting high-impact clinical research priorities for the Society for Vascular Surgery. J Vasc Surg. 2013 Feb; 57(2):493-500. View in PubMed
  75. Conte MS, Owens CD, Belkin M, Creager MA, Edwards KL, Gasper WJ, Kenagy RD, LeBoeuf RC, Sobel M, Clowes A. A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts. J Vasc Surg. 2013 May; 57(5):1179-85.e1-2. View in PubMed
  76. Grenon SM, Jeanne M, Aguado-Zuniga J, Conte MS, Hughes-Fulford M. Effects of gravitational mechanical unloading in endothelial cells: association between caveolins, inflammation and adhesion molecules. Sci Rep. 2013; 3:1494. View in PubMed
  77. Ehsan A, McGraw AP, Aronovitz MJ, Galayda C, Conte MS, Karas RH, Jaffe IZ. Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice. J Thorac Cardiovasc Surg. 2013 Jun; 145(6):1642-9, 1649.e1. View in PubMed
  78. Gasper WJ, Owens CD, Kim JM, Hills N, Belkin M, Creager MA, Conte MS. Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass. J Vasc Surg. 2013 Jan; 57(1):9-18. View in PubMed
  79. Subherwal S, Anstrom KJ, Jones WS, Felker MG, Misra S, Conte MS, Hiatt WR, Patel MR. Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia. Am Heart J. 2012 Sep; 164(3):277-84. View in PubMed
  80. Owens CD, Conte MS. Medical management of peripheral arterial disease: bridging the "gap"? Circulation. 2012 Sep 11; 126(11):1319-21. View in PubMed
  81. Hoel AW, Yu P, Nguyen KP, Sui X, Plescia J, Altieri DC, Conte MS. Mitochondrial heat shock protein-90 modulates vascular smooth muscle cell survival and the vascular injury response in vivo. Am J Pathol. 2012 Oct; 181(4):1151-7. View in PubMed
  82. Creager MA, Kaufman JA, Conte MS. Clinical practice. Acute limb ischemia. N Engl J Med. 2012 Jun 07; 366(23):2198-206. View in PubMed
  83. Conte MS. Diabetic revascularization: endovascular versus open bypass--do we have the answer? Semin Vasc Surg. 2012 Jun; 25(2):108-14. View in PubMed
  84. Johnston PC, Vartanian SM, Runge SJ, Hiramoto JS, Eichler CM, Owens CD, Schneider DB, Conte MS. Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease. J Vasc Surg. 2012 Oct; 56(4):998-1006, 1007.e1; discussion 1006-7. View in PubMed
  85. Hiramoto JS, Owens CD, Kim JM, Boscardin J, Belkin M, Creager MA, Conte MS. Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts. J Vasc Surg. 2012 Aug; 56(2):387-95; discussion 395. View in PubMed
  86. Owens CD, Kim JM, Hevelone ND, Gasper WJ, Belkin M, Creager MA, Conte MS. An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease. J Vasc Surg. 2012 Sep; 56(3):686-95. View in PubMed
  87. Grenon SM, Aguado-Zuniga J, Hatton JP, Owens CD, Conte MS, Hughes-Fulford M. Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion. J Surg Res. 2012 Sep; 177(1):e35-43. View in PubMed
  88. Pillai PS, Leeson S, Porter TF, Owens CD, Kim JM, Conte MS, Serhan CN, Gelman S. Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients. Inflammation. 2012 Feb; 35(1):98-113. View in PubMed
  89. Oka RK, Conte MS, Owens CD, Rapp J, Fung G, Alley HF, Giacomini JC, Myers J, Mohler ER. Efficacy of optimal long-term management of multiple cardiovascular risk factors (CVD) on walking and quality of life in patients with peripheral artery disease (PAD): protocol for randomized controlled trial. Vasc Med. 2012 Feb; 17(1):17-28. View in PubMed
  90. Grenon SM, Hughes-Fulford M, Rapp J, Conte MS. Polyunsaturated fatty acids and peripheral artery disease. Vasc Med. 2012 Feb; 17(1):51-63. View in PubMed
  91. Nabzdyk CS, Lancero H, Nguyen KP, Salek S, Conte MS. RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2011 Nov; 301(5):H1841-9. View in PubMed
  92. Conte MS, Nugent HM, Gaccione P, Roy-Chaudhury P, Lawson JH. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. J Vasc Surg. 2011 Nov; 54(5):1383-9. View in PubMed
  93. Conte MS. Regarding "results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial". J Vasc Surg. 2011 May; 53(5):1453-4; author reply 1454. View in PubMed
  94. Bafford R, Sui XX, Park M, Miyahara T, Newfell BG, Jaffe IZ, Romero JR, Adler GK, Williams GH, Khalil RA, Conte MS. Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization. Am J Physiol Heart Circ Physiol. 2011 Jul; 301(1):H41-7. View in PubMed
  95. Goodney PP, Schanzer A, Demartino RR, Nolan BW, Hevelone ND, Conte MS, Powell RJ, Cronenwett JL. Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg. 2011 Jul; 54(1):100-108.e4. View in PubMed
  96. Conte MS. Discussion. Open surgical revascularization for wound healing: past performance and future directions; and Critical evaluation of endovascular surgery for limb salvage. Plast Reconstr Surg. 2011 Jan; 127 Suppl 1:174S-176S. View in PubMed
  97. Owens CD, Wake N, Kim JM, Hentschel D, Conte MS, Schanzer A. Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease. J Vasc Access. 2010 Oct-Dec; 11(4):329-34. View in PubMed
  98. Conte MS. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes. J Am Podiatr Med Assoc. 2010 Sep-Oct; 100(5):429-38. View in PubMed
  99. Conte MS. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes. J Vasc Surg. 2010 Sep; 52(3 Suppl):96S-103S. View in PubMed
  100. Conte MS. Understanding objective performance goals for critical limb ischemia trials. Semin Vasc Surg. 2010 Sep; 23(3):129-37. View in PubMed
  101. Ho KJ, Spite M, Owens CD, Lancero H, Kroemer AH, Pande R, Creager MA, Serhan CN, Conte MS. Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol. 2010 Oct; 177(4):2116-23. View in PubMed
  102. Grenon SM, Conte MS. Aspirin prophylaxis (100 mg daily) does not improve cardiovascular outcomes compared to placebo in asymptomatic individuals with incidental low-ankle brachial index. Evid Based Med. 2010 Aug; 15(4):106-8. View in PubMed
  103. Conte MS. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. J Vasc Surg. 2010 May; 51(5 Suppl):69S-75S. View in PubMed
  104. Schanzer A, Conte MS. Critical limb ischemia. Curr Treat Options Cardiovasc Med. 2010 Jun; 12(3):214-29. View in PubMed
  105. Rybicki FJ, Mitsouras D, Owens CD, Whitmore A, Gerhard-Herman M, Wake N, Cai T, Zhou Q, Conte MS, Creager MA, Mulkern RV. Multi-contrast high spatial resolution black blood inner volume three-dimensional fast spin echo MR imaging in peripheral vein bypass grafts. Int J Cardiovasc Imaging. 2010 Aug; 26(6):683-91. View in PubMed
  106. Owens CD, Kim JM, Hevelone ND, Hamdan A, Raffetto JD, Creager MA, Conte MS. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein. J Vasc Surg. 2010 May; 51(5):1152-9. View in PubMed
  107. Conte MS, Nugent HM, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson JH. Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. J Vasc Surg. 2009 Dec; 50(6):1359-68.e1. View in PubMed
  108. Conte MS, Belkin M. Surgical revascularization. Introduction. Semin Vasc Surg. 2009 Dec; 22(4):207-8. View in PubMed
  109. Conte MS. Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes? Semin Vasc Surg. 2009 Dec; 22(4):227-33. View in PubMed
  110. Geraghty PJ, Matsumura JS, Conte MS. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals. J Vasc Surg. 2009 Dec; 50(6):1459-61. View in PubMed
  111. Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, Moneta GL, Nehler MR, Powell RJ, Sidawy AN. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009 Dec; 50(6):1462-73.e1-3. View in PubMed
  112. Mitsouras D, Owens CD, Conte MS, Ersoy H, Creager MA, Rybicki FJ, Mulkern RV. In vivo differentiation of two vessel wall layers in lower extremity peripheral vein bypass grafts: application of high-resolution inner-volume black blood 3D FSE. Magn Reson Med. 2009 Sep; 62(3):607-15. View in PubMed
  113. Owens CD, Wake N, Conte MS, Gerhard-Herman M, Beckman JA. In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation. J Vasc Surg. 2009 Nov; 50(5):1063-70. View in PubMed
  114. Hoel AW, Kayssi A, Brahmanandam S, Belkin M, Conte MS, Nguyen LL. Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. J Vasc Surg. 2009 Aug; 50(2):349-54. View in PubMed
  115. Schanzer A, Goodney PP, Li Y, Eslami M, Cronenwett J, Messina L, Conte MS. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg. 2009 Oct; 50(4):769-75; discussion 775. View in PubMed
  116. Robinson WP, Owens CD, Nguyen LL, Chong TT, Conte MS, Belkin M. Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage. J Vasc Surg. 2009 Jun; 49(6):1416-25. View in PubMed
  117. Chong T, Nguyen L, Owens CD, Conte MS, Belkin M. Suprarenal aortic cross-clamp position: a reappraisal of its effects on outcomes for open abdominal aortic aneurysm repair. J Vasc Surg. 2009 Apr; 49(4):873-80. View in PubMed
  118. Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS. Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation. 2009 Jan 06; 119(1):123-30. View in PubMed
  119. Gray BH, Conte MS, Dake MD, Jaff MR, Kandarpa K, Ramee SR, Rundback J, Waksman R. Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art. Circulation. 2008 Dec 16; 118(25):2864-72. View in PubMed
  120. Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg. 2008 Dec; 48(6):1464-71. View in PubMed
  121. Ebaugh JL, Gagnon D, Owens CD, Conte MS, Raffetto JD. Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures. Am J Surg. 2008 Nov; 196(5):634-40. View in PubMed
  122. Owens CD, Ho KJ, Conte MS. Risk factors for failure of lower-extremity revascularization procedures: are they different for bypass and percutaneous procedures? Semin Vasc Surg. 2008 Sep; 21(3):143-53. View in PubMed
  123. Ho KJ, Owens CD, Longo T, Sui XX, Ifantides C, Conte MS. C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta. Am J Physiol Heart Circ Physiol. 2008 Sep; 295(3):H1132-H1140. View in PubMed
  124. Owens CD, Rybicki FJ, Wake N, Schanzer A, Mitsouras D, Gerhard-Herman MD, Conte MS. Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation. J Vasc Surg. 2008 Jun; 47(6):1235-42. View in PubMed
  125. Schanzer A, Hevelone N, Owens CD, Beckman JA, Belkin M, Conte MS. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg. 2008 Apr; 47(4):774-781. View in PubMed
  126. Mitsouras D, Mulkern RV, Owens CD, Conte MS, Ersoy H, Luu TM, Whitmore AG, Creager MA, Rybicki FJ. High-resolution peripheral vein bypass graft wall studies using high sampling efficiency inner volume 3D FSE. Magn Reson Med. 2008 Mar; 59(3):650-4. View in PubMed
  127. Conte MS. Buflomedil in peripheral arterial disease: trials and tribulations. Circulation. 2008 Feb 12; 117(6):717-9. View in PubMed
  128. Brahmanandam S, Ding EL, Conte MS, Belkin M, Nguyen LL. Clinical results of carotid artery stenting compared with carotid endarterectomy. J Vasc Surg. 2008 Feb; 47(2):343-9. View in PubMed
  129. Owens CD, Ho KJ, Conte MS. Lower extremity vein graft failure: a translational approach. Vasc Med. 2008 Feb; 13(1):63-74. View in PubMed
  130. Rybicki FJ, Mitsouras D, Owens CD, Whitmore AG, Ersoy H, Mulkern RV, Creager MA, Conte MS. Lower extremity peripheral vein bypass graft wall thickness changes demonstrated at 1 and 6 months after surgery with ultra-high spatial resolution black blood inner volume three-dimensional fast spin echo magnetic resonance imaging. Int J Cardiovasc Imaging. 2008 Jun; 24(5):529-33. View in PubMed
  131. Nguyen LL, Brahmanandam S, Bandyk DF, Belkin M, Clowes AW, Moneta GL, Conte MS. Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg. 2007 Dec; 46(6):1191-1197. View in PubMed
  132. Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, Moneta GL, Conte MS. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg. 2007 Dec; 46(6):1180-90; discussion 1190. View in PubMed
  133. Hoel AW, Wang GJ, Simosa HF, Conte MS. Regulation of vascular smooth muscle cell growth by survivin. Vascular. 2007 Nov-Dec; 15(6):344-9. View in PubMed
  134. Berceli SA, Hevelone ND, Lipsitz SR, Bandyk DF, Clowes AW, Moneta GL, Conte MS. Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg. 2007 Dec; 46(6):1173-1179. View in PubMed
  135. Conte MS. Molecular engineering of vein bypass grafts. J Vasc Surg. 2007 Jun; 45 Suppl A:A74-81. View in PubMed
  136. Schanzer A, Hoel A, Owens CD, Wake N, Nguyen LL, Conte MS, Belkin M. Restenosis after carotid endarterectomy performed with routine intraoperative duplex ultrasonography and arterial patch closure: a contemporary series. Vasc Endovascular Surg. 2007 Jun-Jul; 41(3):200-5. View in PubMed
  137. Greenberg BL, Glick M, Goodchild J, Duda PW, Conte NR, Conte M. Screening for cardiovascular risk factors in a dental setting. J Am Dent Assoc. 2007 Jun; 138(6):798-804. View in PubMed
  138. Schanzer A, Owens CD, Conte MS, Belkin M. Superficial femoral artery percutaneous intervention is an effective strategy to optimize inflow for distal origin bypass grafts. J Vasc Surg. 2007 Apr; 45(4):740-3. View in PubMed
  139. Owens CD, Ho KJ, Kim S, Schanzer A, Lin J, Matros E, Belkin M, Conte MS. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg. 2007 May; 45(5):944-52. View in PubMed
  140. Hoel AW, Conte MS. Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in vein bypass. Cardiovasc Drug Rev. 2007; 25(3):221-34. View in PubMed
  141. Owens CD, Ridker PM, Belkin M, Hamdan AD, Pomposelli F, Logerfo F, Creager MA, Conte MS. Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg. 2007 Jan; 45(1):2-9; discussion 9. View in PubMed
  142. Nguyen LL, Moneta GL, Conte MS, Bandyk DF, Clowes AW, Seely BL. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg. 2006 Nov; 44(5):977-83; discussion 983-4. View in PubMed
  143. Nguyen LL, Lipsitz SR, Bandyk DF, Clowes AW, Moneta GL, Belkin M, Conte MS. Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events. J Vasc Surg. 2006 Nov; 44(5):971-5; discussion 975-6. View in PubMed
  144. Owens CD, Wake N, Jacot JG, Gerhard-Herman M, Gaccione P, Belkin M, Creager MA, Conte MS. Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness. J Vasc Surg. 2006 Oct; 44(4):740-6. View in PubMed
  145. Bafford R, Sui XX, Wang G, Conte M. Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia. Surgery. 2006 Aug; 140(2):289-96. View in PubMed
  146. Conte MS, Altieri DC. Survivin regulation of vascular injury. Trends Cardiovasc Med. 2006 May; 16(4):114-7. View in PubMed
  147. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Berceli SA, DeMasi RJ, Samson RH, Berman SS. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006 Apr; 43(4):742-751; discussion 751. View in PubMed
  148. Conte M, Broder HL, Jenkins G, Reed R, Janal MN. Oral health, related behaviors and oral health impacts among homeless adults. J Public Health Dent. 2006; 66(4):276-8. View in PubMed
  149. Cunningham LD, Conte MS. Lower-extremity arterial disease. Perspect Vasc Surg Endovasc Ther. 2005 Dec; 17(4):351-61. View in PubMed
  150. Chew DK, Nguyen LL, Owens CD, Conte MS, Whittemore AD, Gravereaux EC, Menard MT, Belkin M. Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage. J Vasc Surg. 2005 Oct; 42(4):695-701. View in PubMed
  151. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg. 2005 Sep; 42(3):456-64; discussion 464-5. View in PubMed
  152. Wang GJ, Sui XX, Simosa HF, Jain MK, Altieri DC, Conte MS. Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein. Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2081-7. View in PubMed
  153. Simosa HF, Wang G, Sui X, Peterson T, Narra V, Altieri DC, Conte MS. Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype. J Vasc Surg. 2005 Apr; 41(4):682-90. View in PubMed
  154. Conte MS, Lorenz TJ, Bandyk DF, Clowes AW, Moneta GL, Seely BL. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg. 2005 Jan-Feb; 39(1):15-23. View in PubMed
  155. Chandiwal A, Balasubramanian V, Baldwin ZK, Conte MS, Schwartz LB. Gene therapy for the extension of vein graft patency: a review. Vasc Endovascular Surg. 2005 Jan-Feb; 39(1):1-14. View in PubMed
  156. Nguyen LL, Conte MS, Menard MT, Gravereaux EC, Chew DK, Donaldson MC, Whittemore AD, Belkin M. Infrainguinal vein bypass graft revision: factors affecting long-term outcome. J Vasc Surg. 2004 Nov; 40(5):916-23. View in PubMed
  157. Chew DK, Conte MS, Khalil RA. Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction. J Vasc Surg. 2004 Nov; 40(5):1001-10. View in PubMed
  158. Nguyen LL, Conte MS, Reed AB, Belkin M. Carotid endarterectomy: who is the high-risk patient? Semin Vasc Surg. 2004 Sep; 17(3):219-23. View in PubMed
  159. Simosa HF, Conte MS. Genetic therapy for vein bypass graft disease: current perspectives. Vascular. 2004 Jul-Aug; 12(4):213-7. View in PubMed
  160. Abbruzzese TA, Havens J, Belkin M, Donaldson MC, Whittemore AD, Liao JK, Conte MS. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg. 2004 Jun; 39(6):1178-85. View in PubMed
  161. Menard MT, Nguyen LL, Chan RK, Conte MS, Fahy L, Chew DK, Donaldson MC, Mannick JA, Whittemore AD, Belkin M. Thoracovisceral segment aneurysm repair after previous infrarenal abdominal aortic aneurysm surgery. J Vasc Surg. 2004 Jun; 39(6):1163-70. View in PubMed
  162. Jacot JG, Abdullah I, Belkin M, Gerhard-Herman M, Gaccione P, Polak JF, Donaldson MC, Whittemore AD, Conte MS. Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling. J Vasc Surg. 2004 Mar; 39(3):547-55. View in PubMed
  163. Reed AB, Gaccione P, Belkin M, Donaldson MC, Mannick JA, Whittemore AD, Conte MS. Preoperative risk factors for carotid endarterectomy: defining the patient at high risk. J Vasc Surg. 2003 Jun; 37(6):1191-9. View in PubMed
  164. Reed AB, Conte MS, Donaldson MC, Mannick JA, Whittemore AD, Belkin M. The impact of patient age and aortic size on the results of aortobifemoral bypass grafting. J Vasc Surg. 2003 Jun; 37(6):1219-25. View in PubMed
  165. Menard MT, Chew DK, Chan RK, Conte MS, Donaldson MC, Mannick JA, Whittemore AD, Belkin M. Outcome in patients at high risk after open surgical repair of abdominal aortic aneurysm. J Vasc Surg. 2003 Feb; 37(2):285-92. View in PubMed
  166. Mann MJ, Conte MS. Transcription factor decoys for the prevention of vein bypass graft failure. Am J Cardiovasc Drugs. 2003; 3(2):79-85. View in PubMed
  167. Conte MS, Mann MJ, Simosa HF, Rhynhart KK, Mulligan RC. Genetic interventions for vein bypass graft disease: a review. J Vasc Surg. 2002 Nov; 36(5):1040-52. View in PubMed
  168. Lau H, Chew DK, Whittemore AD, Belkin M, Conte MS, Donaldson MC. Transaortic endarterectomy for primary mesenteric revascularization. Vasc Endovascular Surg. 2002 Sep-Oct; 36(5):335-41. View in PubMed
  169. Blanc-Brude OP, Yu J, Simosa H, Conte MS, Sessa WC, Altieri DC. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med. 2002 Sep; 8(9):987-94. View in PubMed
  170. Chew DK, Owens CD, Belkin M, Donaldson MC, Whittemore AD, Mannick JA, Conte MS. Bypass in the absence of ipsilateral greater saphenous vein: safety and superiority of the contralateral greater saphenous vein. J Vasc Surg. 2002 Jun; 35(6):1085-92. View in PubMed
  171. Gangadharan SP, Reed AB, Chew DK, Conte MS, Belkin M, Whittemore AD, Donaldson MC. Initial experience with minimally invasive in situ bypass procedure with blind valvulotomy. J Vasc Surg. 2002 Jun; 35(6):1100-6. View in PubMed
  172. Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS, Liao JK. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res. 2002 May 17; 90(9):1020-7. View in PubMed
  173. Conte MS, VanMeter GA, Akst LM, Clemons T, Kashgarian M, Bender JR. Endothelial cell seeding influences lesion development following arterial injury in the cholesterol-fed rabbit. Cardiovasc Res. 2002 Feb 01; 53(2):502-11. View in PubMed
  174. Reed AB, Conte MS, Belkin M, Mannick JA, Whittemore AD, Donaldson MC. Usefulness of autogenous bypass grafts originating distal to the groin. J Vasc Surg. 2002 Jan; 35(1):48-54; discussion, 54-5. View in PubMed
Data provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Michael S. Conte, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.